InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Erck Stanley C, Chairman & CEO. Officer active across 1 companies, notably NOVAVAX INC. Aggregated, 10 filings have been recorded. The latest transaction was disclosed on 1 October 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
6,967 shares
Common Stock
SEC:0001209191-21-070007·
6,967 shares
Common Stock
SEC:0001209191-21-070007:0·
€760,17032,000 shares@ €23.75530.051% mcap53.5% of flow
Common Stock
SEC:0001209191-21-059557·
€333,83814,000 shares@ €23.84560.022% mcap23.5% of flow
Common Stock
SEC:0001209191-21-059552·
€760,17032,000 shares@ €23.75530.051% mcap26.7% of flow
Common Stock
SEC:0001209191-21-059557:0·
€333,83814,000 shares@ €23.84560.022% mcap11.7% of flow
Common Stock
SEC:0001209191-21-059552:0·
6,546 shares
Common Stock
SEC:0001209191-21-057939·
6,546 shares
Common Stock
SEC:0001209191-21-057939:0·
€328,06515,181 shares@ €21.61020.022% mcap23.1% of flow
Common Stock
SEC:0001209191-21-045558·
€328,06515,181 shares@ €21.61020.022% mcap11.5% of flow
Common Stock
SEC:0001209191-21-045558:0·
10 of 10 declarations
About Erck Stanley C
Stanley C. Erck is the President and CEO at NOVAVAX INC. He leads strategic operations and ensures sustainable growth for the company. His leadership is essential in guiding innovation and performance.
